XOMAO Company Profile and Key Details

NASDAQ : XOMAO

XOMA

$25.44

0.0519+0.20%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

XOMA Corporation (XOMAO) stock surged +0.20%, trading at $25.44 on NASDAQ, up from the previous close of $25.39. The stock opened at $25.45, fluctuating between $25.44 and $25.45 in the recent session.

Stock Snapshot

25.3901

Prev. Close

305.19M

Market Cap

25.442

Day Low

25.42

P/E Ratio

1.001

EPS (TTM)

-2.86

Cash Flow per Share

25.45

Open

12M

Number of Shares

25.45

Day High

98.43%

Free Float in %

7.73

Book Value

1.31K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 18, 2026	25.45	25.45	25.44	25.44	1.32K
Mar 17, 2026	25.40	25.40	25.39	25.39	796
Mar 16, 2026	25.30	25.48	25.30	25.36	3.57K
Mar 13, 2026	25.48	25.48	25.48	25.48	178
Mar 12, 2026	25.45	25.45	25.40	25.40	425
Mar 11, 2026	25.52	25.52	25.37	25.37	2.77K
Mar 10, 2026	25.49	25.49	25.40	25.48	744
Mar 09, 2026	25.33	25.42	25.30	25.30	2.43K
Mar 06, 2026	25.43	25.48	25.33	25.43	2.67K
Mar 03, 2026	25.46	25.49	25.39	25.39	2.17K
Mar 02, 2026	25.47	25.47	25.32	25.47	1.42K
Feb 27, 2026	25.46	25.48	25.41	25.41	1.47K
Feb 26, 2026	25.34	25.44	25.34	25.41	1.22K
Feb 25, 2026	25.40	25.41	25.32	25.32	2.1K
Feb 24, 2026	25.35	25.44	25.35	25.42	1.2K
Feb 23, 2026	25.31	25.40	25.31	25.40	2.73K
Feb 20, 2026	25.37	25.40	25.31	25.40	2.85K
Feb 19, 2026	25.37	25.38	25.30	25.38	2.11K
Feb 18, 2026	25.36	25.37	25.36	25.37	655
Feb 17, 2026	25.36	25.36	25.34	25.36	1.16K

Contact Details

EmeryVille, CA 94608

United States

https://www.xoma.com 510 204 7200

About Company

XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Stock Peers

REGN

-14.93-1.97%

Regeneron Pharmaceuticals, Inc.$744.12 ARGX

-21.26-3.01%

argenx SE$684.77 UTHR

-9.67-1.79%

United Therapeutics Corporation$530.35 VRTX

-10.9-2.36%

Vertex Pharmaceuticals Incorporated$451.59 MDGL

-1.18-0.27%

Madrigal Pharmaceuticals, Inc.$442.00 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 ALNY

-5.62-1.75%

Alnylam Pharmaceuticals, Inc.$314.80 PRAX

-14.59-4.81%

Praxis Precision Medicines, Inc.$288.79 KRYS

-5.5-2.15%

Krystal Biotech, Inc.$250.83 SGEN

-0.16-0.07%

Seagen Inc.$228.74

Company Overview

XOMA Corporation (NASDAQ:XOMAO) closed at $25.44 USD, gaining $0.05 (0.20%) from the previous close of $25.39. The stock is currently within 5% of its 52-week high $23.32 and $25.76. With a market capitalization of about $305.19 million, XOMA Corporation is classified as a small-cap and shows market-like volatility (beta ~0.83). Key stats such as the average daily volume over the past year has been around 2.51 thousand shares, volume is running light vs its 52-week average. Headquartered in EmeryVille, CA, XOMA Corporation operates in the Healthcare sector and the Biotechnology industry. Led by CEO Owen Hughes Jr., the company employs approximately 13 people and listed since April 12, 2021. XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific.

Technical Performance

Average 10-day trading volume of 1.53 thousand shares is below the 3-month average of 2.56 thousand, indicating normal recent market interest.

Valuation Metrics

XOMA Corporation trades at a P/E ratio of 16.91, slightly below the S&P 500 average, with a price-to-sales ratio of 6.53 and a price-to-book ratio of 5.92 trading at moderately above to book value. The P/FCF stands at 121.92, also above market averages.

Dividend & Fair Value

XOMA Corporation last paid a dividend of 2.09 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$30.15. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

XOMA Corporation earnings surprise history is a mixed track record. The quarter that ended November 12, 2025, missed forecasts by -2037.5%. The prior quarter beat by -444.67%. Over the last six quarters, Apple has recorded several small beats. These include 16.48% in March 17, 2025.

Financial & Profitability Overview

Over the trailing twelve months, XOMA generated $4.76M in revenue, or $0.41 per share. Gross margin was 81.08%, operating margin -460.03%, and net profit margin -858.15%. Returns are negative, with ROA at -17.43% and ROE at -46.02%.
On valuation metrics, XOMA trades at a P/E of 16.91, P/S of 6.53 and P/B of 5.92. The current ratio is 3.37 and quick ratio is 3.37. Operationally, the company’s inventory turnover is 0.00 and cash conversion cycle is -237.63 days , indicating it collects cash faster than it pays suppliers. Debt-to-equity is 1.57, supported by a cash flow-to-debt ratio of 0.02.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, XOMA posted revenue of $4.76M, down slightly from $6.03M in the prior quarter. Gross profit was $3.86M (margin 81.08%). Operating income was - $21.89M (margin -460.0%). Net income was- $40.83M (EPS - $3.56).
The company ended the quarter with $153.61M in cash and short-term investments, a total debt of $124.45M, and net debt of - $29.00M. Total assets were $234.30M, with equity of $88.72M. Financials further reflected weakness, with operating cash flow of - $18.16M, free cash flow of - $32.83M, and capital expenditures of - $14.67M.

Price Forecast & Outlook

Our AI price prediction model suggests that XOMA Corporation stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -14.47%, with price expected at $21.76 by November 24, 2023, within a range of $21.37 to $22.14

Key Takeaways

XOMA Corporation (NASDAQ:XOMAO) shares are flat -5.26% year-to-date Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows XOMA Corporation trading at a premium to the broader market with a P/E of 16.91.

Frequently Asked Questions

What is the current XOMA Corporation (XOMAO) stock price?

XOMA Corporation (NASDAQ: XOMAO) stock price is $25.44 in the last trading session. During the trading session, XOMAO stock reached the peak price of $25.45 while $25.44 was the lowest point it dropped to. The percentage change in XOMAO stock occurred in the recent session was 0.2% while the dollar amount for the price change in XOMAO stock was $0.05.

XOMAO's industry and sector of operation?

The NASDAQ listed XOMAO is part of Biotechnology industry that operates in the broader Healthcare sector. XOMA Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of XOMAO?

No Data

How XOMAO did perform over past 52-week?

XOMAO's closing price is 9.1% higher than its 52-week low of $23.32 where as its distance from 52-week high of $25.76 is -1.23%.

How many employees does XOMAO have?

Number of XOMAO employees currently stands at 13.

Link for XOMAO official website?

Official Website of XOMAO is: https://www.xoma.com

How do I contact XOMAO?

XOMAO could be contacted at phone 510 204 7200 and can also be accessed through its website. XOMAO operates from 2200 Powell Street, EmeryVille, CA 94608, United States.

How many shares of XOMAO are traded daily?

XOMAO stock volume for the day was 1.31K shares. The average number of XOMAO shares traded daily for last 3 months was 2.51K.

What is the market cap of XOMAO currently?

The market value of XOMAO currently stands at $305.19M with its latest stock price at $25.44 and 12M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	13
Beta	0.83
Sales or Revenue	$4.76M
5Y Sales Change%	-0.345%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

XOMAO Company Profile and Key Details

XOMA

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Stock Snapshot

Technical Performance

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Dividend & Fair Value

Key Takeaways

Company Overview

Valuation Metrics